5 Oversold Biotech Stocks To Buy Right Now

2. Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX)

Number of Hedge Fund Holders: 36

14-day RSI Value: 20.5

Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) is based in Cambridge, Massachusetts. It is a commercial-stage biotech company that develops treatments for amyotrophic lateral sclerosis and neurodegenerative diseases.

We saw 36 hedge funds long Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) in the fourth quarter, with a total stake value of $329.7 million.

A Buy rating and an $8 price target were maintained on Amylyx Pharmaceuticals Inc. (NASDAQ:AMLX) on March 12 by Andrew Fein at HC Wainwright & Co.

Follow Amylyx Pharmaceuticals Inc.